Related references
Note: Only part of the references are listed.Minimally invasive surgery for cervical cancer: consequences for treatment after LACC Study
Rainer Kimmig et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)
Gearing up T-cell immunotherapy in cervical cancer
Shilpa Raghuvanshi Chauhan et al.
CURRENT PROBLEMS IN CANCER (2018)
Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis
Mintu Pal et al.
EXPERIMENTAL CELL RESEARCH (2018)
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context
Hua-Sheng Chiu et al.
CELL REPORTS (2018)
The PTENP1 Pseudogene, Unlike the PTEN Gene, Is Methylated in Normal Endometrium, As Well As in Endometrial Hyperplasias and Carcinomas in Middle-Aged and Elderly Females
T. F. Kovalenko et al.
ACTA NATURAE (2018)
Role and mechanism of action of LRIG1 in ovarian cancer cell line and VP16 drug-resistant cell line
Yaqi Zhang et al.
ONCOLOGY LETTERS (2017)
Aqueous Huaier Extract Suppresses Gastric Cancer Metastasis and Epithelial to Mesenchymal Transition by Targeting Twist
Zhiyuan Xu et al.
JOURNAL OF CANCER (2017)
Pseudogene PTENP1 Suppresses Gastric Cancer Progression by Modulating PTEN
Xiaoqiang Guo et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study
Salvatore Vaccarella et al.
LANCET ONCOLOGY (2016)
Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation
Chiu-Ling Chen et al.
BIOMATERIALS (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence
S. Vaccarella et al.
BRITISH JOURNAL OF CANCER (2014)
Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression
Gan Yu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo
M. Yu et al.
ONCOGENE (2014)
MiR-141 Suppresses the Migration and Invasion of HCC Cells by Targeting Tiam1
Ying Liu et al.
PLOS ONE (2014)
Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma
Baek-Hui Kim et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Over-Expression of miR-106b Promotes Cell Migration and Metastasis in Hepatocellular Carcinoma by Activating Epithelial-Mesenchymal Transition Process
Wing Lung Yau et al.
PLOS ONE (2013)
Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
David J. Mulholland et al.
CANCER RESEARCH (2012)
Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs
Yvonne Tay et al.
CELL (2011)
In Vivo Identification of Tumor-Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma
Florian A. Karreth et al.
CELL (2011)
Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15INK4B tumor suppressor gene
Y. Kotake et al.
ONCOGENE (2011)
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Laura Poliseno et al.
NATURE (2010)
Identification of the miR-106b∼25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation
Laura Poliseno et al.
SCIENCE SIGNALING (2010)
Emerging Role of miR-106b-25/miR-17-92 Clusters in the Control of Transforming Growth Factor β Signaling
Fabio Petrocca et al.
CANCER RESEARCH (2008)
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression
Irena Ivanovska et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Share Paper
